Skip to main content
Log in

The pharmacokinetics and pharmacodynamics of ketamine in dogs anesthetized with enflurane

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The plasma concentration vs. anesthetic effect relationships for ketamine are not well known. It is desirable to establish stable and predictable drug concentrations in plasma (and brain) in order to define such relationships. As a prelude to pharmacodynamic studies, we investigated ketamine pharmacokinetics in eight dogs anesthetized with enflurane and correlated ketamine concentration in plasma (KET) with its ability to reduce the enflurane concentration required for anesthesia (enflurane EC50: MAC-the endtidal concentration at which half the dogs moved in response to damping of the tail and half did not move). Four dogs (Group 1) received ketamine 10 mg/kg iv over 30 sec. Blood for determination of KET was collected repeatedly over the 5-h period following injection. Based on the pharmacokinetic parameters determined for Group I, four dogs in Group 2 received ketamine as a continuous infusion of 300 μg·kg−1·min−1 for 5hr accompanied by an initial loading dose (26 mg/kg administered over 20 min) designed to produce a stable KET of 20 μg/ml of plasma. Enflurane MAC and KET were determined regularly during the infusion and for 5 hr after discontinuation of the infusion. There were no significant differences in the following pharmacokinetic parameters determined for Group 1 vs. Group2:\(t_{\mathop 2\limits^ \bot \beta } \)=122±9 vs. 141±40min (\(\bar x\)±SD) and CL±8.1±5.9 vs. 13.9±2.5ml·kg−1min−1, respectively. When administered as a continuous infusion (Group 2), KET remained relatively stable at 22.1±4.6 μg/ml for 5hr. The degree of MAC reduction remained relatively stable at 73% during the continuous infusion. Finally, the enflurane MAC reduction vs. KET was established over a wide range of plasma concentrations in 4 additional dogs (Group 3). This study determined that the pharmacokinetics of ketamine were consistent under two different experimental conditions and demonstrated the relationship between plasma concentration and anesthetic effect in the dog.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. P. F. White, W. L. Way, and A. J. Trevor. Ketamine-Its pharmacology and therapeutic uses.Anesthesiology 56:119–136 (1982).

    Article  CAS  PubMed  Google Scholar 

  2. M. R. Murphy and C. C. Hug, Jr.. The anesthetic potency of fentanyl in terms of its reduction of enfluraneMAC.Anesthesiology 57:485–488 (1982).

    Article  CAS  PubMed  Google Scholar 

  3. J. G. Wagner. A safe method for rapidly achieving plasma concentration plateaus.Clin. Pharmacol. Ther. 16:691–700 (1974).

    CAS  PubMed  Google Scholar 

  4. M. Gibaldi and D. Perrier.Pharmacokinetics, 2ed, Marcel Dekker, New York, 1982, pp. 45–111; 113–144; 409–417.

    Google Scholar 

  5. M. R. Murphy and C. C. Hug, Jr. Humaneness of anesthetic induction technique questioned (Letter to editor).Anesthesiology 59:260–261 (1983).

    Article  Google Scholar 

  6. R. L. Stiller, J. A. Pajerski, P. G. Dayton, J. M. Perel, and C. C. Hug, Jr.. Gas chromatographic analysis of ketamine and norketamine in plasma and urine: Nitrogen-sensitive detection.J. Chromatog. 232:305–314 (1982).

    Article  CAS  Google Scholar 

  7. Statistical Consultants, Inc. PCNONLIN and PCNONLIN 84: Software for the statistical analysis of nonlinear models.Am. Statist. 40:52 (1986).

    Article  Google Scholar 

  8. H. G. Boxenbaum, S. Riegelman, and R. M. Elsahoff. Statistical estimations in pharmacokinetics.J. Pharmacokin. Biopharm. 2:123–148 (1974).

    Article  CAS  Google Scholar 

  9. J. S. Kaka and W. L. Hayton. Pharmacokinetics of ketamine and two metabolites in the dog.J. Pharmacokin. Biopharm. 8:193–202 (1980).

    Article  CAS  Google Scholar 

  10. L. Irestedt and M. Andreen. Effects of enflurane on hemodynamics and oxygen consumption in the dog with special reference to the liver and preportal tissues.Acta Anaesth. Scand. 23:13–26 (1979).

    Article  CAS  PubMed  Google Scholar 

  11. R. L. Hughes, D. Campbell, and W. Fitch. Effects of enflurane and halothane on liver blood flow and oxygen consumption in the greyhound.Br. J. Anaesth. 52:1079–1086 (1980).

    Article  CAS  PubMed  Google Scholar 

  12. S. S. Hanna. Measurement of liver blood flow by galactose clearance.Can. J. Surg. 27:218–220 (1984).

    CAS  PubMed  Google Scholar 

  13. J. A. Clements and W. S. Nimmo. Pharmacokinetics and analgesic effect of ketamine in man.Br. J. Anaesth. 53:27–30 (1981).

    Article  CAS  PubMed  Google Scholar 

  14. J. Wieber, R. Gugler, J. H. Hengstmann, and H. J. Dengler. Pharmacokinetics of ketamine in man.Anaesthetist 24:260–263 (1975).

    CAS  Google Scholar 

  15. E. F. Domino, E. K. Zsigmond, L. E. Domino, K. E. Domino, S. P. Kothary, and S. E. Domino. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay.Anesth. Analg. 61:87–92 (1982).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by a grant from the Swiss National Fund.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwieger, I.M., Szlam, F. & Hug, C.C. The pharmacokinetics and pharmacodynamics of ketamine in dogs anesthetized with enflurane. Journal of Pharmacokinetics and Biopharmaceutics 19, 145–156 (1991). https://doi.org/10.1007/BF01073866

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01073866

Key words

Navigation